Company Overview

Visienco is a biotech company that provides a standardized, scalable, and automated platform for organoid sorting and 3D model analysis.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

Access detailed peer comparisons, multiples, and valuation benchmarks.

Historical fundraising activity

Notable investors and investment history

Investor	Rounds
W.A. de Vigier Foundation	Grant
Nvidia Inception	Accelerator
Ypsomed Innovation Fund Foundation	Grant

Structured signals derived from secondary market and firmographic data.

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about Visienco's valuation, stock price, and market status.

HeadquartersRoot

Year Founded2025

Last FundingFeb 4, 2026

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.